Aerovate Therapeutics logo

Aerovate Therapeutics Share Price Today

(NASDAQ: AVTE)

Aerovate Therapeutics share price is $2.48 & ₹215.68 as on 6 Mar 2025, 2.30 'hrs' IST

$2.48

0.06

(2.48%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Aerovate Therapeutics share price in Dollar and Rupees. Guide to invest in Aerovate Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aerovate Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Aerovate Therapeutics share price movements

  • Today's Low: $2.42
    Today's High: $2.49

    Day's Volatility :2.82%

  • 52 Weeks Low: $1.25
    52 Weeks High: $32.42

    52 Weeks Volatility :96.14%

Aerovate Therapeutics (AVTE) Returns

PeriodAerovate Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-5.47%
2.1%
0.0%
6 Months
24.74%
-4.1%
0.0%
1 Year
-89.86%
2.2%
0.0%
3 Years
-78.45%
11.8%
-11.6%

Aerovate Therapeutics (AVTE) Key Statistics

in dollars & INR

Previous Close
$2.42
Open
$2.45
Today's High
$2.49
Today's Low
$2.4199
Market Capitalization
$69.6M
Today's Volume
$32.1K
52 Week High
$32.415
52 Week Low
$1.25
Revenue TTM
$0.0
EBITDA
$-74.3M
Earnings Per Share (EPS)
$-2.98
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-74.91%

How to invest in Aerovate Therapeutics Stock (AVTE) from India?

It is very easy for Indian residents to invest directly in Aerovate Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aerovate Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aerovate Therapeutics or AVTE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aerovate Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aerovate Therapeutics shares which would translate to 0.351 fractional shares of Aerovate Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aerovate Therapeutics, in just a few clicks!

Returns in Aerovate Therapeutics (AVTE) for Indian investors in Rupees

The Aerovate Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aerovate Therapeutics investment value today

Current value as on today

₹15,352

Returns

₹84,648

(-84.65%)

Returns from Aerovate Therapeutics Stock

₹89,610 (-89.61%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Aerovate Therapeutics (AVTE)

-71%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Aerovate Therapeutics Stock from India on INDmoney has decreased by -71% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Aerovate Therapeutics

  • RA Capital Management, LLC

    31.71%

  • Sofinnova Ventures

    12.97%

  • TCG Crossover Management, LLC

    7.73%

  • BRAIDWELL LP

    4.97%

  • Logos Global Management LP

    4.83%

  • Vanguard Group Inc

    3.46%

Analyst Recommendation on Aerovate Therapeutics

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Aerovate Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
12
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Aerovate Therapeutics Stock (AVTE)

What analysts predicted

Downside of 5.92%

Target:

$2.33

Current:

$2.48

Insights on Aerovate Therapeutics Stock (Ticker Symbol: AVTE)

  • Price Movement

    In the last 1 year, AVTE stock has moved down by -89.4%
  • AVTE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 151.7%
  • AVTE vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 125.3%

Aerovate Therapeutics Technicals Summary

Sell

Neutral

Buy

Aerovate Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Aerovate Therapeutics (AVTE) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aerovate Therapeutics Inc logo
-5.84%
24.74%
-89.86%
-78.45%
-83.91%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aerovate Therapeutics Inc logo
0.88
NA
NA
-0.46
-0.75
-0.45
NA
2.64
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aerovate Therapeutics Inc logo
Buy
$69.6M
-83.91%
0.88
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Aerovate Therapeutics

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Organization
Aerovate Therapeutics
Employees
30
CEO
Mr. Timothy P. Noyes M.B.A.
Industry
Healthcare

Management People of Aerovate Therapeutics

NameTitle
Mr. Timothy P. Noyes M.B.A.
CEO & Director
Mr. George A. Eldridge
CFO & Treasurer
Dr. Benjamin T. Dake Ph.D.
Founder, President, COO & Secretary
Dr. Ralph W. Niven M.B.A., M.R, Ph.D., Pharm.S
Chief Scientific Officer
Mr. Hunter Gillies M.D.
Chief Medical Officer
Ms. Donna Dea
Head of Regulatory Affairs
Ms. Susan Fischer
Executive Vice President of Development Operations
Mr. Stephen K. Yu
Senior Vice President of Quality
Dr. Sanjeev Khindri
Executive Vice President of Clinical Development
Dr. Cheryl Lassen BSc., M.D., MBBCh
Senior Vice President of Clinical Development

Important FAQs about investing in AVTE Stock from India :

What is Aerovate Therapeutics share price today?

Aerovate Therapeutics share price today stands at $2.48, Open: $2.45 ; Previous Close: $2.42 ; High: $2.49 ; Low: $2.42 ; 52 Week High: $32.42 ; 52 Week Low: $1.25.

The stock opens at $2.45, after a previous close of $2.42. The stock reached a daily high of $2.49 and a low of $2.42, with a 52-week high of $32.42 and a 52-week low of $1.25.

Can Indians buy Aerovate Therapeutics shares?

Yes, Indians can invest in the Aerovate Therapeutics (AVTE) from India.

With INDmoney, you can buy Aerovate Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aerovate Therapeutics at zero transaction cost.

How can I buy Aerovate Therapeutics shares from India?

It is very easy to buy Aerovate Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aerovate Therapeutics (AVTE) be purchased?

Yes, you can buy fractional shares of Aerovate Therapeutics with INDmoney app.

What are the documents required to start investing in Aerovate Therapeutics stocks?

To start investing in Aerovate Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aerovate Therapeutics Stock (AVTE)?

Today’s highest price of Aerovate Therapeutics (AVTE) is $2.49.

Today’s lowest price of Aerovate Therapeutics (AVTE) is $2.42.

What is today's market capitalisation of Aerovate Therapeutics?

Today's market capitalisation of Aerovate Therapeutics AVTE is 69.6M

What is the 52 Week High and Low Range of Aerovate Therapeutics Stock (AVTE)?

  • 52 Week High

    $32.42

  • 52 Week Low

    $1.25

What are the historical returns of Aerovate Therapeutics (AVTE)?

  • 1 Month Returns

    -5.84%

  • 3 Months Returns

    24.74%

  • 1 Year Returns

    -89.86%

  • 5 Years Returns

    -83.91%

Who is the Chief Executive Officer (CEO) of Aerovate Therapeutics ?

Mr. Timothy P. Noyes M.B.A. is the current Chief Executive Officer (CEO) of Aerovate Therapeutics.